This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Veeva Systems (VEEV) Just Reclaimed the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Veeva Systems (VEEV) Unveils New Study Training Application
by Zacks Equity Research
Veeva Systems' (VEEV) new clinical study training application will address the demands and complexities involved in present-day trials.
Veeva Systems (VEEV) Beats on Q1 Earnings, Ups FY23 View
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal Q1 results reflect impressive performances by both of its segments.
Veeva Systems (VEEV) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Veeva (VEEV) delivered earnings and revenue surprises of 7.61% and 1.95%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
Semtech (SMTC) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Semtech (SMTC) is expected to have gained from integrations in the LoRa business and the growing adoption of the BlueRiver technology in first-quarter fiscal 2023.
Reasons to Retain Integer Holdings (ITGR) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and solid foothold in the broader MedTech space.
Factors to Note Ahead of Pure Storage's (PSTG) Q1 Earnings
by Zacks Equity Research
Pure Storage's (PSTG) fiscal first-quarter performance will likely gain from strong adoption of subscription services like Pure as-a-Service, Portworx and Evergreen offerings.
Asana (ASAN) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Asana's (ASAN) first-quarter results are likely to reflect benefits from top-of-the-funnel investments and expansion of its enterprise customer base.
Here's Why You Should Retain PerkinElmer (PKI) Stock Now
by Zacks Equity Research
PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.
Factors to Note Ahead of NetApp's (NTAP) Q4 Earnings Release
by Zacks Equity Research
NetApp's (NTAP) fiscal fourth-quarter performance is likely to reflect strength in the Public Cloud Services and all-flash storage business
NextGen Healthcare (NXGN) Unveils Health Data Hub Insights
by Zacks Equity Research
NextGen Healthcare's (NXGN) newly launched tool can help healthcare providers to receive a complete picture of the community and patient health.
Here's Why You Should Retain Merit Medical (MMSI) Stock Now
by Zacks Equity Research
Investors continue to be optimistic about Merit Medical (MMSI) due to its strong product portfolio.
Veeva Systems (VEEV) Vault CTMS to Aid Clinical Trial Management
by Zacks Equity Research
Veeva System's (VEEV) Vault CTMS to streamline complex trial processes for more than 150 companies.
Digital Turbine (APPS) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Digital Turbine's (APPS) fourth-quarter 2022 earnings are expected to have benefited from the solid performance of the content media and fyber business.
Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio
by Zacks Equity Research
Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.
Abbott (ABT) to Commence Limited Release of EleCare Soon
by Zacks Equity Research
Abbott's (ABT) release of limited quantities of EleCare branded specialty formulas to be free of charge to children in need.
Pinduoduo (PDD) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Pinduoduo's (PDD) first-quarter results are expected to reflect online marketing services' strength. However, uncertainties related to the pandemic are likely to have acted as a headwind.
Box (BOX) Q1 Earnings Lag Estimates
by Zacks Equity Research
Box (BOX) delivered earnings and revenue surprises of -8% and 1.81%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
Veeva Systems (VEEV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Veeva (VEEV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Must Add Masimo (MASI) Stock to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.
Masimo's (MASI) PVi Favored by New Study for Pediatric Patients
by Zacks Equity Research
Masimo's (MASI) PVi is expected to take better treatment decisions for pediatric patients with signs of obstructive respiratory disease in the EDs.
NextGen Healthcare's (NXGN) Solutions Selected by MHHC
by Zacks Equity Research
NextGen Healthcare's (NXGN) solutions get chosen by MHHC that can help serve the latter's rapidly growing community efficiently.
Veeva Systems (VEEV) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal first-quarter results are likely to reflect a solid show by its segments and robust product portfolio.
The Zacks Analyst Blog Highlights 8x8, Duck Creek Technologies, Paycom Software and Veeva Systems
by Zacks Equity Research
8x8, Duck Creek Technologies, Paycom Software and Veeva Systems have been included in this Analyst Blog.
Shockwave Medical's (SWAV) IVL Cleared for Use in China
by Zacks Equity Research
Shockwave Medical's (SWAV) latest regulatory approval is expected to serve a wider patient pool.